Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis | Conference Material / Slide Presentation | MSF Science Portal
Conference Material
|Slide Presentation
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis
